Herbalife Ltd. (HLF) exhibits 77.9% gross margins and 34.4% return on invested capital within Health Care (Other Pharmaceuticals), balanced against a 5.4x enterprise multiple and 4.8% implied options volatility.
Sustained 77.9% gross profitability converts into 9.5% operating margin and 34.4% ROIC, outpacing sector cost of capital.
ROIC: 34.4% // GM: 77.9%YoY revenue trajectory of +0.9% paired with 18.66% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +0.9% // FCF YLD: 18.66%Altman Z-Score of 2.39 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.39 // F-SCORE: 6/9Trading at 5.9x trailing P/E (5.5x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 5.9x // EV/EBITDA: 5.4xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $12.93 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Other Pharmaceuticals require continuous execution to defend 4.5% net margins.
NET MARGIN: 4.5% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for HLF & activate live FRED threshold breach alerts.